Effects of folic acid withdrawal on transcriptomic profiles in murine triple-negative breast cancer cell lines

• Published in: Biochimie Vol. 173; pp. 114 - 122
• Main Authors: Kok, Dieuwertje E., O’Flanagan, Ciara H., Coleman, Michael F., Ashkavand, Zahra, Hursting, Stephen D., Krupenko, Sergey A.
• Format: Journal Article
• Language: English
• Published: France Elsevier B.V 01.06.2020
• Subjects: Animals; breast neoplasms; Cell Line, Tumor; Culture Media; Epithelial-Mesenchymal Transition; Epithelial-to-mesenchymal transition; epithelium; Female; Folic acid; Folic Acid - administration & dosage; gene expression; humans; Interferon signaling; interferons; metabolism; Metastasis; Mice; Mice, Transgenic; microarray technology; neoplasm cells; phenotype; therapeutics; Transcriptome; Transcriptomics; Triple Negative Breast Neoplasms - metabolism; Triple-negative breast cancer; Wnt Signaling Pathway; Interferon signaling; Metastasis; Transcriptomics; Epithelial-to-mesenchymal transition; Folic acid; Triple-negative breast cancer
• ISSN: 0300-9084; 1638-6183; 1638-6183
• DOI: 10.1016/j.biochi.2020.04.005

We have previously shown that withdrawal of folic acid led to metabolic reprogramming and a less aggressive phenotype in a mouse cell model of triple-negative breast cancer (TNBC). Herein, we evaluate the effects of folic acid withdrawal on transcriptomic profiles in these cells. Murine cell lines were originally derived from a pool of spontaneous mammary tumors grown in MMTV-Wnt1 transgenic mice. Based on their differential molecular characteristics and metastatic potential, these cell lines were previously characterized as non-metastatic epithelial (E-Wnt), non-metastatic mesenchymal (M-Wnt) and metastatic mesenchymal (metM-Wntliver) cells. Using custom two-color 180K Agilent microarrays, we have determined gene expression profiles for three biological replicates of each subtype kept on standard medium (2.2 μM folic acid) or folic acid-free medium for 72 h. The analyses revealed that more genes were differentially expressed upon folic acid withdrawal in M-Wnt cells (1884 genes; Benjamini-Hochberg-adjusted P-value <0.05) compared to E-Wnt and metM-Wntliver cells (108 and 222 genes, respectively). Pathway analysis has identified that type I interferon signaling was strongly affected by folic acid withdrawal, with interferon-responsive genes consistently being upregulated upon folic acid withdrawal in M-Wnt cells. Of note, repressed interferon signaling has been established as one of the characteristics of aggressive human TNBC, and hence reactivation of this pathway may be a promising therapeutic approach. Overall, while our study indicates that the response to folic acid withdrawal varies by molecular subtype and cellular phenotype, it also underscores the necessity to further investigate one-carbon metabolism as a potential therapeutic means in the treatment of advanced TNBC. •Folic acid withdrawal alters gene expression in mouse mammary cancer cell lines.•Changes are most pronounced in non-metastatic mesenchymal cells.•Interferon signaling pathway genes are upregulated by folic acid withdrawal.•Reactivation of the type I interferon pathway may have clinical utility.